مورد إلكتروني

Serum Osteoprotegerin in Patients with Calcified Aortic Valve Stenosis in Relation to Heart Failure

التفاصيل البيبلوغرافية
العنوان: Serum Osteoprotegerin in Patients with Calcified Aortic Valve Stenosis in Relation to Heart Failure
عناروين إضافية: Serumska vrijednost osteoprotegerina u bolesnika s kalcificirajućom aortnom stenozom u ovisnosti o zatajenju srca
المصدر: Acta clinica Croatica; ISSN 0353-9466 (Print); ISSN 1333-9451 (Online); Volume 56.; Issue 4.
بيانات النشر: Sestre Milosrdnice University hospital and Institute of Clinical Medical Research 2017
تفاصيل مُضافة: Sandra Makarović
Zorin Makarović
Ines Bilić-Ćurčić
Jasminka Milas-Ahić
Ivan Mihaljević
Maja Franceschi
Tomislav Jukić
نوع الوثيقة: Electronic Resource
مستخلص: The aim of the study was to assess the role of serum osteoprotegerin (OPG) as a biomarker in patients with aortic valve stenosis (AS) in relation to heart failure and symptomatic status. This was a case control study, which included 51 patients with AS and 39 control subjects. At the time of study enrolment, detailed medical history was obtained and all subjects underwent physical examination, chest x-ray and echocardiography. OPG levels were measured in all subjects, and serum N-terminal of the pro b-type natriuretic peptide (NT pro BNP) levels were determined in patients with AS. Serum OPG levels were elevated in patients with AS compared to control subjects (p=0.001). Pa-tients with heart failure due to AS had elevated serum OPG levels in comparison to patients without heart failure (p=0.001). A significant correlation between OPG and symptomatic status was observed in all patients with AS (p<0.001), however, it was not the case in patients without heart failure (p=0.425). There was a positive correlation between OPG and NT pro BNP concentrations with objective signs of heart failure on chest x-ray (p<0.001). Negative correlation of OPG concentrations with aortic valve area was present (p<0.040), as well as with left ventricular ejection fraction (p<0.001). Serum OPG could be a valuable biomarker in the evaluation of severity of calcified AS and serve as an additional indicator besides clinical presentation and echocardiography in the assessment of surgical treatment or aortic valve replacement.
Cilj ove studije bio je ocijeniti ulogu osteoprotegerina (OPG) kao biljega u bolesnika sa stenozom aortnog srčanog za-liska u odnosu na prisutne simptome kao i stupanj srčanog zatajenja. U studiju je bio uključen 51 bolesnik s aortnom steno-zom (AS) i 39 kontrolnih ispitanika. Prije uključenja u studiju uzeta je detaljna anamneza, učinjen je fizikalni pregled, ren-tgenska snimka srca i pluća te ehokardiografija. OPG je određen u svih ispitanika, a N-terminalni nastavak pro b-tipa natriu-retskog peptida (NT pro BNP) bio je određen u bolesnika s AS. OPG je bio povišen u bolesnika s AS u odnosu na kontrolne ispitanike (p=0,001). Bolesnici sa srčanim zatajenjem zbog AS imali su povišene razine OPG-a u odnosu na bolesnike bez srčanog zatajenja (p=0,001). Značajna korelacija između OPG-a i simptomatskog statusa bila je zapažena u svih bolesnika s AS (p<0,001), ali to nije bio slučaj u bolesnika bez srčanog zatajenja (p=0.425). Zabilježena je i pozitivna korelacija između koncentracije OPG-a i NT pro BNP-a s objektivnim znakovima srčanog zatajenja na rentgenskoj snimci srca i pluća (p<0,001). Također je opažena negativna korelacija OPG-a i areje aortnog zaliska (p<0,040) te istisne frakcije lijeve klijetke (p<0,001). OPG bi mogao predstavljati vrijedan biljeg u procjeni težine kalcificirane AS te bi mogao poslužiti kao dodatni indikator prilikom odlučivanja o kirurškom liječenju ili zamjeni aortnog zaliska, naravno, uz kliničku prezentaciju i ehokardiografiju.
مصطلحات الفهرس: Osteoprotegerin – blood; Aortic valve stenosis – pathology; Calcinosis – blood; Heart failure; Biomarkers – blood; Natriuretic peptides, Osteoprotegerin – krv; Aortni srčani zalistak, stenoza – patologija; Kalcinoza – krv; Srčano zatajivanje; Biomarkeri – krv; Natriuretični peptidi, text, info:eu-repo/semantics/article, info:eu-repo/semantics/publishedVersion
URL: https://hrcak.srce.hr/195471
https://hrcak.srce.hr/file/288151
info:eu-repo/semantics/altIdentifier/doi/10.20471/acc.2017.56.04.22
الإتاحة: Open access content. Open access content
info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-nd/4.0
ملاحظة: application/pdf
English
أرقام أخرى: HRCAK oai:hrcak.srce.hr:195471
1033695005
المصدر المساهم: HRCAK PORTAL ZNANSTVENIH CASOPISA REPUB
From OAIster®, provided by the OCLC Cooperative.
رقم الأكسشن: edsoai.on1033695005
قاعدة البيانات: OAIster